March 12, 2024
navigateleft
navigateright
Antitrust Scrutiny of “Roll Up” Strategies Heats Up as US Agencies Examine Private Equity Healthcare Deals
Contributor(s)
Most Read
navigateleft
navigateright
navigateleft
navigateright
EUMR in the Face of Conglomerates and Ecosystems: A Framework to Assess Complex and Multifaceted Effects of Mergers on Competition
April 18, 2024
|Brussels, Belgium
Speaker(s)
The Merger Control Forum 2024: Examining Recent Cases in Big Tech and Digital Markets
April 18, 2024
|Central London
Speaker(s)
The Next Phase of Merger Control: Implications of the CMA’s Procedural Reforms for Complex Global Mergers
March 6, 2024
|Competition Law Association
Speaker(s)
GCR Live: Law Leaders Global
January 31, 2024
Speaker(s)
Novel Theories of How Mergers Harm Competition
November 14, 2023
Speaker(s)
Unlocking Antitrust – Updates on Merger Enforcement
November 1, 2023
Speaker(s)
The Rise of Ecosystem Theories: Where are we after Microsoft/Activision and Booking/etraveli?
October 31, 2023
Speaker(s)
Weil Around the Web
Weils Antitrust Excellence Recognized as Microsoft Activision Deal Wins Three Honors at GC...
Global Competition Review has recognized Weil’s success as global antitrust counsel to...
Read More
Weil Advised Arcosa in its Acquisition of Ameron Pole Products
Weil represented Arcosa, Inc. (NYSE: ACA) in the completion of its acquisition of Ameron Pole...
Read More
Weils 2024 Litigation Trends Report
On behalf of Weil’s global Litigation Department, we are pleased to introduce our 2024...
Read More
Weil Advises PSG on Its Sale of Nalanda to Once for All
Weil is advising PSG on its sale of Nalanda to Once For All, a portfolio company of GTCR. As part...
Read More
Weil Advises Seven2 Portfolio Company Vitaprotech in Acquisition
Weil is advising Seven2 portfolio company Vitaprotech in its acquisition of the physical security,...
Read More
Weil Advises ChampionX in its Sale to SLB
Weil is representing ChampionX Corporation (NASDAQ: CHX) in its definitive agreement for SLB (NYSE:...
Read More
Recent Accolades and Recognition
By the Numbers